
Learn
WHAT IS MICRODOSING

Psilocybin
THE ULTIMATE
GUIDE TO MICRODOSING
Psilocybin mushrooms are fungi containing psilocybin, a natural psychedelic compound known for inducing intense hallucinations and mystical experiences. Commonly referred to as "magic mushrooms" or "shrooms," they are found in over 180 species worldwide and have a rich history in Mesoamerican spiritual practices. Beyond recreational use, they are widely utilized in therapeutic contexts to address conditions such as cluster headaches, OCD, anxiety, depression, PTSD, and addiction. Despite being decriminalized in a few North American cities, they remain illegal at the federal level in the U.S. as a Schedule I substance. Recent FDA recognition of psilocybin as a "breakthrough therapy" for depression suggests potential accelerated development for medical applications through controlled studies.

Explore
ALL ABOUT MICRODOSING

Benefits of Microdosing
Across various historical cultures, psychedelic mushrooms have long been revered for their profound capacity to facilitate healing and transformation. Beyond their cultural significance, contemporary research is shedding light on their potential therapeutic benefits on a significant scale. Studies conducted both in the United States and internationally are demonstrating that psychoactive mushrooms can catalyze profound personal growth. For instance, a recent study highlighted in the Journal of Psychopharmacology revealed that a single dose of psilocybin led to substantial and enduring reductions in depressed mood and anxiety, accompanied by improvements in overall quality of life.
Moreover, the mystical experiences associated with psilocybin, which gained attention during the 1960s psychedelic movement in America, are now the subject of rigorous scientific exploration. Emerging evidence strongly suggests that psilocybin holds promise as a potent healer. Specifically, ongoing clinical trials are examining the effects of high-dose psilocybin experiences on patients with life-threatening cancer diagnoses. These trials aim to assess how psilocybin, administered in therapeutic settings, can alleviate the psychological distress and anxiety often associated with such diagnoses. Initial findings under double-blind, placebo-controlled conditions indicate that a single high dose of psilocybin can significantly reduce symptoms of psychological distress in terminal patients, with lasting effects.
Furthermore, research indicates that psilocybin's efficacy may be linked to its ability to influence neuroplasticity—the brain's capacity to adapt, grow, and change. This growing body of research underscores the potential of psilocybin mushrooms not only as a therapeutic tool but also as a catalyst for profound psychological and spiritual transformation.
FREQUENTLY ASKED QUESTIONS
- 01
- 02
- 03
- 04
- 05
- 06
- 07





